Atai Life Sciences N.V. (ATAI)

$4.48 -0.80 (-15.15%)
Market Cap 1.25B
Revenue (ttm) 310,000.00
Net Income (ttm) -149.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -48,151.61%
Debt to Equity Ratio 0.00
Volume 10,284,041
Avg Vol 5,985,524
Day's Range N/A - N/A
Shares Out 233.78M
Stochastic %K 10%
Beta 1.59
Analysts Strong Sell
Price Target $12.12

Company Profile

AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 332 282 0507
Address:
250 West 34th Street, New York, United States
Lanuchbox
Lanuchbox Jun. 29 at 12:28 PM
$ATAI
0 · Reply
leLu83
leLu83 Jun. 29 at 12:12 PM
$ATAI you pretty much michael saylor atai but instead of a valueless nothing, youre investing in the most undervalued ticker in the nasdaq. You buy. You hold. You enter long term cap gains tax status. For those needing to flip and to get a larger share count, the time comes soon on news. Bags in single trading days. Id suspect a 7am EST PR tomorrow tuesday to formally announce dosing for p3 bpl003. 12 week trial with BTD and the CEO saying the expedited timeline has to he kept confidential for competitive purposes means this bad boy will be in the market at the end of 2027. This coupled with data that blows all others away NOT including the fact and most crucial to commercialization....90 minute experience. Its a fking blockbuster drug! And if the other vls01 hits numbers its an insane re valuation of the pipeline. GET SIZE NOW. 🐳
0 · Reply
banker4fun
banker4fun Jun. 29 at 11:44 AM
$ATAI @leLu83 i’d like to see you take a leadership position on this board and make the call for today. Are we pumping? Is today going to be a pivotal day in the history of ATAI? Show that you have the pulse and speak truth so the rest of us can make the trade. FOREVER SILENCE THE NAYSAYERS AND CRITICS WITH A SINGLE MIC DROP CALL 
0 · Reply
GSP
GSP Jun. 29 at 11:38 AM
$IVF $ATAI $BB $PYXS $WKSP
0 · Reply
banker4fun
banker4fun Jun. 29 at 11:28 AM
$ATAI
0 · Reply
leLu83
leLu83 Jun. 29 at 5:35 AM
$ATAI pushing commas like a MF
0 · Reply
LurkerLongtime
LurkerLongtime Jun. 29 at 3:45 AM
$ATAI how are we feeling. I voted red 😬
0 · Reply
Jpsolomon513
Jpsolomon513 Jun. 29 at 3:06 AM
$ATAI cry about it tard
0 · Reply
twiggs462
twiggs462 Jun. 29 at 1:27 AM
$CMPS $DFTX $ATAI Great PBS video... https://youtu.be/g9z1bqK1sco?is=4108rA4Krw_IiD9u
0 · Reply
mwhite9869
mwhite9869 Jun. 29 at 12:06 AM
$ATAI 5.35$ on RH right now. Looking like a we might keep things rolling tomorrow morning! GLA!
1 · Reply
Latest News on ATAI
AtaiBeckley to be added to Russell 2000, Russell 3000 Indexes at open on 6/29

2026-06-25T10:06:15.000Z - 4 days ago

AtaiBeckley to be added to Russell 2000, Russell 3000 Indexes at open on 6/29

AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets

Jun 25, 2026, 6:00 AM EDT - 4 days ago

AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets

AtaiBeckley Transcript: 7th Annual HCW Neuro Perspectives Hybrid Conference

Jun 15, 2026, 7:00 AM EDT - 14 days ago

AtaiBeckley Transcript: 7th Annual HCW Neuro Perspectives Hybrid Conference

AtaiBeckley Transcript: AGM 2026

Jun 4, 2026, 11:00 AM EDT - 24 days ago

AtaiBeckley Transcript: AGM 2026

AtaiBeckley Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 12:15 PM EDT - 25 days ago

AtaiBeckley Transcript: Jefferies Global Healthcare Conference 2026

AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations

May 28, 2026, 9:00 AM EDT - 4 weeks ago

AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations

AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026

May 27, 2026, 6:00 AM EDT - 4 weeks ago

AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026

Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings

2026-05-14T18:50:44.000Z - 6 weeks ago

Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings

CMND CMPS DFTX ENVB GHRS MIRA NRXP

AtaiBeckley reports Q1 EPS (8c), consensus (11c)

2026-05-12T16:08:09.000Z - 6 weeks ago

AtaiBeckley reports Q1 EPS (8c), consensus (11c)

AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update

May 12, 2026, 8:00 AM EDT - 6 weeks ago

AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update

AtaiBeckley Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 6 weeks ago

AtaiBeckley Quarterly report: Q1 2026

Analysts see 200%+ upside in these 3 high-risk stocks: here's why?

May 9, 2026, 11:53 AM EDT - 7 weeks ago

Analysts see 200%+ upside in these 3 high-risk stocks: here's why?

ACTU VVOS

AtaiBeckley Transcript: Needham Virtual Psychedelics Forum

Apr 27, 2026, 11:00 AM EDT - 2 months ago

AtaiBeckley Transcript: Needham Virtual Psychedelics Forum

AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research

Apr 27, 2026, 4:05 AM EDT - 2 months ago

AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research

AtaiBeckley Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

AtaiBeckley Proxy statement: Proxy filing

AtaiBeckley Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

AtaiBeckley Proxy statement: Proxy filing

AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder

Apr 22, 2026, 6:00 AM EDT - 2 months ago

AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder

How Trump's psychedelics executive order could unlock stalled cannabis reform

Apr 20, 2026, 2:05 PM EDT - 2 months ago

How Trump's psychedelics executive order could unlock stalled cannabis reform

CMPS DFTX HELP GHRS

Psychedelic Stocks Surge After Trump Signs Order Fast-Tracking Drug Research

Apr 20, 2026, 10:45 AM EDT - 2 months ago

Psychedelic Stocks Surge After Trump Signs Order Fast-Tracking Drug Research

CMPS DFTX GHRS

AtaiBeckley price target raised to $15 from $14 at Canaccord

2026-04-20T13:22:59.000Z - 2 months ago

AtaiBeckley price target raised to $15 from $14 at Canaccord

Psychedelic stocks rally with Trump's support

Apr 20, 2026, 8:26 AM EDT - 2 months ago

Psychedelic stocks rally with Trump's support

CMPS DFTX GHRS

Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring.

Apr 20, 2026, 8:18 AM EDT - 2 months ago

Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring.

CMPS GHRS DFTX

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

Apr 20, 2026, 6:43 AM EDT - 2 months ago

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

CMPS DFTX ENVB GHRS HELP

AtaiBeckley price target raised to $16 from $11 at Guggenheim

2026-04-17T12:28:41.000Z - 2 months ago

AtaiBeckley price target raised to $16 from $11 at Guggenheim

AtaiBeckley Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 16, 2026, 12:45 PM EDT - 2 months ago

AtaiBeckley Transcript: 25th Annual Needham Virtual Healthcare Conference

AtaiBeckley to Participate in Upcoming Needham Healthcare Conferences

Apr 14, 2026, 6:00 AM EDT - 2 months ago

AtaiBeckley to Participate in Upcoming Needham Healthcare Conferences

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

2026-04-09T15:00:20.000Z - 2 months ago

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

NRXP PBM SILO

AtaiBeckley announces peer-reviewed Phase 2a results of BPL-003 study

2026-04-08T10:07:08.000Z - 2 months ago

AtaiBeckley announces peer-reviewed Phase 2a results of BPL-003 study

AtaiBeckley's BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs

Apr 8, 2026, 6:00 AM EDT - 2 months ago

AtaiBeckley's BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs

AtaiBeckley initiated with a Buy at Deutsche Bank

2026-03-27T08:55:15.000Z - 3 months ago

AtaiBeckley initiated with a Buy at Deutsche Bank

AtaiBeckley initiated with a Buy at Deutsche Bank

2026-03-26T23:25:13.000Z - 3 months ago

AtaiBeckley initiated with a Buy at Deutsche Bank

AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst

Mar 24, 2026, 6:00 AM EDT - 3 months ago

AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst

AtaiBeckley Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 8:00 AM EDT - 3 months ago

AtaiBeckley Transcript: Leerink Global Healthcare Conference 2026

BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day

Mar 10, 2026, 6:00 AM EDT - 3 months ago

BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day

AtaiBeckley Earnings release: Q4 2025

Mar 6, 2026, 12:30 PM EST - 4 months ago

AtaiBeckley Earnings release: Q4 2025

AtaiBeckley Annual report: Q4 2025

Mar 6, 2026, 12:30 PM EST - 4 months ago

AtaiBeckley Annual report: Q4 2025

AtaiBeckley Transcript: Investor Day 2026

Mar 6, 2026, 9:00 AM EST - 4 months ago

AtaiBeckley Transcript: Investor Day 2026

AtaiBeckley Slides: FY 2026

Mar 6, 2026, 9:00 AM EST - 4 months ago

AtaiBeckley Slides: FY 2026

AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update

Mar 6, 2026, 7:00 AM EST - 4 months ago

AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update

AtaiBeckley Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 11:50 AM EST - 4 months ago

AtaiBeckley Transcript: TD Cowen 46th Annual Health Care Conference

AtaiBeckley Transcript: Study result

Feb 26, 2026, 8:00 AM EST - 4 months ago

AtaiBeckley Transcript: Study result

AtaiBeckley Press release: Study result

Feb 26, 2026, 8:00 AM EST - 4 months ago

AtaiBeckley Press release: Study result

AtaiBeckley Slides: Study result

Feb 26, 2026, 8:00 AM EST - 4 months ago

AtaiBeckley Slides: Study result

AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder

Feb 26, 2026, 7:00 AM EST - 4 months ago

AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder

AtaiBeckley To Host Virtual Investor Day on March 6, 2026

Feb 20, 2026, 7:00 AM EST - 4 months ago

AtaiBeckley To Host Virtual Investor Day on March 6, 2026

AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation

Jan 16, 2026, 7:00 AM EST - 5 months ago

AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation

AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference

Jan 8, 2026, 7:00 AM EST - 6 months ago

AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

Dec 23, 2025, 7:00 AM EST - 6 months ago

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

AtaiBeckley Transcript: Jefferies London Healthcare Conference 2025

Nov 20, 2025, 6:30 AM EST - 7 months ago

AtaiBeckley Transcript: Jefferies London Healthcare Conference 2025

Enhanced Fortifies Executive Leadership Team & Board of Directors

Nov 19, 2025, 7:32 PM EST - 7 months ago

Enhanced Fortifies Executive Leadership Team & Board of Directors

AtaiBeckley Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

AtaiBeckley Quarterly report: Q3 2025

AtaiBeckley Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

AtaiBeckley Earnings release: Q3 2025

AtaiBeckley Transcript: Study Result

Nov 10, 2025, 8:00 AM EST - 8 months ago

AtaiBeckley Transcript: Study Result

AtaiBeckley Press release: Study Result

Nov 10, 2025, 8:00 AM EST - 8 months ago

AtaiBeckley Press release: Study Result

AtaiBeckley Slides: Study Result

Nov 10, 2025, 8:00 AM EST - 8 months ago

AtaiBeckley Slides: Study Result

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

Oct 20, 2025, 5:29 PM EDT - 8 months ago

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

atai Life Sciences Announces Pricing of Public Offering of Common Shares

Oct 16, 2025, 10:31 PM EDT - 9 months ago

atai Life Sciences Announces Pricing of Public Offering of Common Shares

atai Life Sciences Announces Proposed Public Offering of Common Shares

Oct 16, 2025, 4:12 PM EDT - 9 months ago

atai Life Sciences Announces Proposed Public Offering of Common Shares

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression

Oct 16, 2025, 4:10 PM EDT - 9 months ago

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression

AtaiBeckley Proxy statement: Proxy Filing

Oct 16, 2025, 8:00 AM EDT - 9 months ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Proxy statement: Proxy Filing

Oct 10, 2025, 8:00 AM EDT - 9 months ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Proxy statement: Proxy Filing

Sep 29, 2025, 8:00 AM EDT - 9 months ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Proxy statement: Proxy Filing

Sep 24, 2025, 8:00 AM EDT - 9 months ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Proxy statement: Proxy Filing

Sep 23, 2025, 8:00 AM EDT - 9 months ago

AtaiBeckley Proxy statement: Proxy Filing

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression

Sep 23, 2025, 7:00 AM EDT - 9 months ago

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression

AtaiBeckley Transcript: TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Sep 17, 2025, 10:00 AM EDT - 10 months ago

AtaiBeckley Transcript: TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

AtaiBeckley Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 11:30 AM EDT - 10 months ago

AtaiBeckley Transcript: H.C. Wainwright 27th Annual Global Investment Conference

AtaiBeckley Transcript: Cantor Global Healthcare Conference 2025

Sep 5, 2025, 8:35 AM EDT - 10 months ago

AtaiBeckley Transcript: Cantor Global Healthcare Conference 2025

atai Life Sciences to Participate in September Investor Conferences

Aug 28, 2025, 4:05 PM EDT - 10 months ago

atai Life Sciences to Participate in September Investor Conferences

AtaiBeckley Proxy statement: Proxy Filing

Aug 14, 2025, 8:00 AM EDT - 11 months ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

AtaiBeckley Earnings release: Q2 2025

AtaiBeckley Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

AtaiBeckley Quarterly report: Q2 2025

Atai Life Sciences schizophrenia drug fails to meet main goal in mid-stage trial

Jul 25, 2025, 4:16 PM EDT - 1 year ago

Atai Life Sciences schizophrenia drug fails to meet main goal in mid-stage trial

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia

Jul 25, 2025, 4:05 PM EDT - 1 year ago

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia

AtaiBeckley Slides: Corporate Presentation

Jul 2, 2025, 8:30 AM EDT - 1 year ago

AtaiBeckley Slides: Corporate Presentation

AtaiBeckley Proxy statement: Proxy Filing

Jul 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Proxy statement: Proxy Filing

Jul 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Transcript: Study Update

Jul 1, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Transcript: Study Update

AtaiBeckley Press release: Study Update

Jul 1, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Press release: Study Update

AtaiBeckley Slides: Study Update

Jul 1, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Slides: Study Update

AtaiBeckley Proxy statement: Proxy Filing

Jul 1, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

atai Life Sciences Announces $50 Million Private Placement Financing

Jul 1, 2025, 6:05 AM EDT - 1 year ago

atai Life Sciences Announces $50 Million Private Placement Financing

atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression

Jul 1, 2025, 6:00 AM EDT - 1 year ago

atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression

AtaiBeckley Proxy statement: Proxy Filing

Jun 18, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Transcript: H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 17, 2025, 7:00 AM EDT - 1 year ago

AtaiBeckley Transcript: H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

AtaiBeckley Transcript: Jefferies Global Healthcare Conference 2025

Jun 5, 2025, 9:55 AM EDT - 1 year ago

AtaiBeckley Transcript: Jefferies Global Healthcare Conference 2025

AtaiBeckley Proxy statement: Proxy Filing

Jun 3, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Transcript: M&A Announcement

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Transcript: M&A Announcement

AtaiBeckley Press release: M&A Announcement

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Press release: M&A Announcement

AtaiBeckley Slides: M&A Announcement

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Slides: M&A Announcement

AtaiBeckley Proxy statement: Proxy Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Proxy statement: Proxy Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Proxy statement: Proxy Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies

Jun 2, 2025, 6:00 AM EDT - 1 year ago

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies

atai Life Sciences to Participate in Upcoming Investor Conferences

May 29, 2025, 8:30 AM EDT - 1 year ago

atai Life Sciences to Participate in Upcoming Investor Conferences

atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech's Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression

May 20, 2025, 7:00 AM EDT - 1 year ago

atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech's Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression

atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates

May 14, 2025, 7:00 AM EDT - 1 year ago

atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates

AtaiBeckley Quarterly report: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

AtaiBeckley Quarterly report: Q1 2025

AtaiBeckley Earnings release: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

AtaiBeckley Earnings release: Q1 2025

AtaiBeckley Slides: Corporate Presentation

May 14, 2025, 7:00 AM EDT - 1 year ago

AtaiBeckley Slides: Corporate Presentation

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder

May 13, 2025, 7:01 AM EDT - 1 year ago

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder

AtaiBeckley Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing

AtaiBeckley Annual report: Q4 2024

Mar 17, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Annual report: Q4 2024

AtaiBeckley Earnings release: Q4 2024

Mar 17, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Earnings release: Q4 2024

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression

Mar 11, 2025, 7:00 AM EDT - 1 year ago

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression

AtaiBeckley Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 11:50 AM EST - 1 year ago

AtaiBeckley Transcript: TD Cowen 45th Annual Healthcare Conference

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 24, 2025, 4:10 PM EST - 1 year ago

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference

atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health

Jan 10, 2025, 7:00 AM EST - 1 year ago

atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health

AtaiBeckley Quarterly report: Q3 2024

Nov 13, 2024, 8:00 AM EST - 1 year ago

AtaiBeckley Quarterly report: Q3 2024

AtaiBeckley Earnings release: Q3 2024

Nov 13, 2024, 8:00 AM EST - 1 year ago

AtaiBeckley Earnings release: Q3 2024

AtaiBeckley Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Oct 16, 2024, 3:30 PM EDT - 1 year ago

AtaiBeckley Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

IntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AG

Oct 2, 2024, 9:21 AM EDT - 1 year ago

IntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AG

AtaiBeckley Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 10, 2024, 4:30 PM EDT - 1 year ago

AtaiBeckley Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

AtaiBeckley Slides: Corporate Presentation

Sep 10, 2024, 7:00 AM EDT - 1 year ago

AtaiBeckley Slides: Corporate Presentation

atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 7:00 AM EDT - 1 year ago

atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

AtaiBeckley Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 14, 2024, 11:00 AM EDT - 2 years ago

AtaiBeckley Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Aug 13, 2024, 7:10 AM EDT - 2 years ago

atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

AtaiBeckley Quarterly report: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

AtaiBeckley Quarterly report: Q2 2024

AtaiBeckley Earnings release: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

AtaiBeckley Earnings release: Q2 2024

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

Aug 12, 2024, 12:12 PM EDT - 2 years ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

CMPS HELP DFTX

atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference

Aug 7, 2024, 7:00 AM EDT - 2 years ago

atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference

AtaiBeckley Transcript: H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Jun 27, 2024, 7:00 AM EDT - 2 years ago

AtaiBeckley Transcript: H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference

Jun 26, 2024, 7:00 AM EDT - 2 years ago

atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference

atai Life Sciences Announces Update on Beckley Psytech's Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a

Jun 20, 2024, 7:00 AM EDT - 2 years ago

atai Life Sciences Announces Update on Beckley Psytech's Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a

AtaiBeckley Transcript: Jefferies 2024 Global Healthcare Conference

Jun 6, 2024, 10:00 AM EDT - 2 years ago

AtaiBeckley Transcript: Jefferies 2024 Global Healthcare Conference

atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference

May 31, 2024, 7:00 AM EDT - 2 years ago

atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference

Lanuchbox
Lanuchbox Jun. 29 at 12:28 PM
$ATAI
0 · Reply
leLu83
leLu83 Jun. 29 at 12:12 PM
$ATAI you pretty much michael saylor atai but instead of a valueless nothing, youre investing in the most undervalued ticker in the nasdaq. You buy. You hold. You enter long term cap gains tax status. For those needing to flip and to get a larger share count, the time comes soon on news. Bags in single trading days. Id suspect a 7am EST PR tomorrow tuesday to formally announce dosing for p3 bpl003. 12 week trial with BTD and the CEO saying the expedited timeline has to he kept confidential for competitive purposes means this bad boy will be in the market at the end of 2027. This coupled with data that blows all others away NOT including the fact and most crucial to commercialization....90 minute experience. Its a fking blockbuster drug! And if the other vls01 hits numbers its an insane re valuation of the pipeline. GET SIZE NOW. 🐳
0 · Reply
banker4fun
banker4fun Jun. 29 at 11:44 AM
$ATAI @leLu83 i’d like to see you take a leadership position on this board and make the call for today. Are we pumping? Is today going to be a pivotal day in the history of ATAI? Show that you have the pulse and speak truth so the rest of us can make the trade. FOREVER SILENCE THE NAYSAYERS AND CRITICS WITH A SINGLE MIC DROP CALL 
0 · Reply
GSP
GSP Jun. 29 at 11:38 AM
$IVF $ATAI $BB $PYXS $WKSP
0 · Reply
banker4fun
banker4fun Jun. 29 at 11:28 AM
$ATAI
0 · Reply
leLu83
leLu83 Jun. 29 at 5:35 AM
$ATAI pushing commas like a MF
0 · Reply
LurkerLongtime
LurkerLongtime Jun. 29 at 3:45 AM
$ATAI how are we feeling. I voted red 😬
0 · Reply
Jpsolomon513
Jpsolomon513 Jun. 29 at 3:06 AM
$ATAI cry about it tard
0 · Reply
twiggs462
twiggs462 Jun. 29 at 1:27 AM
$CMPS $DFTX $ATAI Great PBS video... https://youtu.be/g9z1bqK1sco?is=4108rA4Krw_IiD9u
0 · Reply
mwhite9869
mwhite9869 Jun. 29 at 12:06 AM
$ATAI 5.35$ on RH right now. Looking like a we might keep things rolling tomorrow morning! GLA!
1 · Reply
duhbledown11
duhbledown11 Jun. 28 at 11:29 PM
$ATAI
0 · Reply
Tifosi007
Tifosi007 Jun. 28 at 8:27 PM
$ATAI This is where it gets interesting. Large active healthcare investors absolutely do analyze things like Phase 3 probability of success, FDA interactions, Cash runway, Commercial opportunity, Valuation versus peers If they believe BPL-003 has meaningful value, they may accumulate before broader recognition. Then Russell inclusion simply forces passive funds to buy as well.
0 · Reply
mwhite9869
mwhite9869 Jun. 28 at 3:15 PM
$ATAI Atai Beckley N.V. (ATAI) In a report released yesterday, Justin Walsh from JonesTrading maintained a Buy rating on Atai Beckley N.V., with a price target of $16.00. The company’s shares closed last Friday at $5.04. According to TipRanks.com, Walsh is a 5-star analyst with an average return of 19.3% and a 37.6% success rate. Walsh covers the Healthcare sector, focusing on stocks such as NeuroOne Medical Technologies, Bioline RX Ltd Sponsored ADR, and Praxis Precision Medicines. Atai Beckley N.V. has an analyst consensus of Strong Buy, with a price target consensus of $16.71, a 271.3% upside from current levels. In a report released yesterday, H.C. Wainwright also reiterated a Buy rating on the stock with a $25.00 price target.
0 · Reply
GSP
GSP Jun. 28 at 2:26 PM
Your Day Trading Watch List for June 29th in About 2 Minutes (con't): $IVF $ATAI $BB $PYXS $WKSP .
0 · Reply
leLu83
leLu83 Jun. 28 at 1:23 AM
$ATAI management is top tier and will perfectly time news with most impact in the macro environment. Smart money trade desks are just front running the inevitable. Load load load the boat they are. Gamme squeeze already in flow...
2 · Reply
andrescuesta97
andrescuesta97 Jun. 27 at 4:48 PM
$ATAI Many months of noise and a lot of whining around this. But to those who held strong and loaded up despite the noise, now is our time to reap and enjoy Best is yet to come!!
1 · Reply
Lanuchbox
Lanuchbox Jun. 27 at 12:31 PM
$ATAI Check out this great informative video on what is going on here https://youtu.be/DjMTUyFu4ek?si=9B5PjLdU98OM90vQ
2 · Reply
JisNice420
JisNice420 Jun. 27 at 9:36 AM
$ATAI held this stock for a while, why is it suddenly exploding lol?
1 · Reply
luminouslumens
luminouslumens Jun. 27 at 3:21 AM
$ATAI $BFLY $WEN $XNDU
0 · Reply
BigCatNY
BigCatNY Jun. 27 at 3:01 AM
$ATAI The Russell inclusion is a positive catalyst. Don't let an early Monday pullback scare you into selling because it may just be short-term volatility. stay strong!
1 · Reply
topstockalerts
topstockalerts Jun. 27 at 2:06 AM
$ATAI the market is showing this stock a lot of respect.
0 · Reply
LurkerLongtime
LurkerLongtime Jun. 27 at 1:11 AM
$ATAI $CMPS I have some buy orders for them when they do. Let's fuckin ride
0 · Reply